Therapeutic advances in hematology

Keyphrases

Publications

volume 14, 2023

Meiru Bu, Xi Deng, Yu Zhang, Sean W Chen, Muliang Jiang, Bihong T Chen
Brain iron content and cognitive function in patients with β-thalassemia. Therapeutic advances in hematology 14 (2023)
Sung Soo Park, Daehun Kwag, Jong-Hyuk Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Sung-Eun Lee
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis. Therapeutic advances in hematology 14 (2023)
Panagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, Michalis Samarkos, Helen Gogas
Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature. Therapeutic advances in hematology 14 (2023)
Wojciech Jurczak, Nagah Elmusharaf, Christopher Paul Fox, Wiliam M Townsend, Amanda G Paulovich, Jeffrey R Whiteaker, Fanny Krantz, Chuan-Chuan Wun, Graeme Parr, Shringi Sharma, Veerendra Munugalavadla, Richa Manwani, Emma Dean, Tahla Munir
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia. Therapeutic advances in hematology 14 (2023)
Fadi G Haddad, Jacki Sawyers, Nicholas James Short
Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Therapeutic advances in hematology 14 (2023)
Catherine M Broome
Efgartigimod alfa for the treatment of primary immune thrombocytopenia. Therapeutic advances in hematology 14 (2023)
Mark T Reding, Ingrid Pabinger, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso, Shadan Lalezari, Wolfgang Miesbach, Giovanni Di Minno, Robert Klamroth, Cedric Hermans
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic advances in hematology 14 (2023)
Mark T Reding, Ingrid Pabinger, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso, Shadan Lalezari, Wolfgang Miesbach, Giovanni Di Minno, Robert Klamroth, Cedric Hermans
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic advances in hematology 14 (2023)
Alexander Ngwube, Hemalatha G Rangarajan, Niketa Shah
Role of abatacept in the prevention of graft- versus -host disease: current perspectives. Therapeutic advances in hematology 14 (2023)
Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, Ming-Sun Yu, Shih-Hao Huang, Alex Jia-Hong Lin, Kuan-Der Lee, Min-Chi Chen
Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study. Therapeutic advances in hematology 14 (2023)
Cedric Hermans, Yves Gruel, Laurent Frenzel, Evelien Krumb
How to translate and implement the current science of gene therapy into haemophilia care? Therapeutic advances in hematology 14 (2023)
Jan Astermark, Cédric Hermans, Monia Ezzalfani, Alaeddine Sidhom, Sylvaine Barbier, Nana Kragh, Aletta Falk, Daniel Eriksson
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes. Therapeutic advances in hematology 14 (2023)
Catherine M Broome
Efgartigimod alfa for the treatment of primary immune thrombocytopenia. Therapeutic advances in hematology 14 (2023)
Na Li, Jianying Lei, Jiahao Zhang, Hongfu Cai, Bin Zheng, Ting Yang, Maobai Liu, Jianda Hu
Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States. Therapeutic advances in hematology 14 (2023)
Mark T Reding, Ingrid Pabinger, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso, Shadan Lalezari, Wolfgang Miesbach, Giovanni Di Minno, Robert Klamroth, Cedric Hermans
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic advances in hematology 14 (2023)
Jan Astermark, Jan Blatny, Christoph Königs, Cedric Hermans, Victor Jiménez-Yuste, Daniel P Hart
Considerations for shared decision management in previously untreated patients with hemophilia A or B. Therapeutic advances in hematology 14 (2023)
Panagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, Michalis Samarkos, Helen Gogas
Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature. Therapeutic advances in hematology 14 (2023)
Meiru Bu, Xi Deng, Yu Zhang, Sean W Chen, Muliang Jiang, Bihong T Chen
Brain iron content and cognitive function in patients with β-thalassemia. Therapeutic advances in hematology 14 (2023)
Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Linchun Xu, Shaoze Lin, Xueyang Xing, Yongzhong Su
Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis. Therapeutic advances in hematology 14 (2023)
Alexander Ngwube, Hemalatha G Rangarajan, Niketa Shah
Role of abatacept in the prevention of graft- versus -host disease: current perspectives. Therapeutic advances in hematology 14 (2023)
Sung Soo Park, Daehun Kwag, Jong-Hyuk Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Sung-Eun Lee
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis. Therapeutic advances in hematology 14 (2023)
Wenrui Yang, Xu Liu, Xin Zhao, Li Zhang, Guangxin Peng, Lei Ye, Kang Zhou, Yuan Li, Jianping Li, Huihui Fan, Yang Yang, Youzhen Xiong, Liping Jing, Fengkui Zhang
Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study. Therapeutic advances in hematology 14 (2023)
Zhe Li, Wei Mu, Min Xiao
Genetic lesions and targeted therapy in Hodgkin lymphoma. Therapeutic advances in hematology 14 (2023)
Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, Ming-Sun Yu, Shih-Hao Huang, Alex Jia-Hong Lin, Kuan-Der Lee, Min-Chi Chen
Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study. Therapeutic advances in hematology 14 (2023)
Wenrui Yang, Xu Liu, Xin Zhao, Li Zhang, Guangxin Peng, Lei Ye, Kang Zhou, Yuan Li, Jianping Li, Huihui Fan, Yang Yang, Youzhen Xiong, Liping Jing, Fengkui Zhang
Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study. Therapeutic advances in hematology 14 (2023)
Alessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, Marco Ruggeri, Sergio Siragusa, Nicola Vianelli, Francesco Zaja, Francesco Rodeghiero
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion. Therapeutic advances in hematology 14 (2023)
Marcelo Lima Ribeiro, Salvador Sánchez-Vinces, Laura Mondragon, Gael Roué
Epigenetic targets in B- and T-cell lymphomas: latest developments. Therapeutic advances in hematology 14 (2023)
Carmen Escuriola-Ettingshausen, Robert Klamroth, Miguel Escobar, Oleksandra Stasyshyn, Srilatha Tangada, Werner Engl, Ivan Honauer, Hye-Youn Lee, Pratima Chowdary, Jerzy Windyga
Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: post hoc subanalysis of the randomized, phase 3 PROPEL study. Therapeutic advances in hematology 14 (2023)
Xiaoyan Lv, Pengpeng Li, Pengpeng Yue, Ping Tang, Fuling Zhou
Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS. Therapeutic advances in hematology 14 (2023)
Zachary D Crees, Michael P Rettig, John F Dipersio
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide. Therapeutic advances in hematology 14 (2023)
Hao Wang, Kristin N Berger, Elizabeth L Miller, Wei Fu, Larisa Broglie, Frederick D Goldman, Heiko Konig, Su Jin Lim, Arthur S Berg, Julie-An Talano, Melanie A Comito, Sherif S Farag, Jeffrey J Pu
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. Therapeutic advances in hematology 14 (2023)
Abiola Oladapo, Scott Kolodny, Michael Vredenburg, Elyse Swallow, Debbie Goldschmidt, Kirthana Sarathy, Priscilla Lopez, Hillary Maitland, John Yee
Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study. Therapeutic advances in hematology 14 (2023)
Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Juan Erviti, María Ximena Rojas Reyes
Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies. Therapeutic advances in hematology 14 (2023)
Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Juan Erviti, María Ximena Rojas Reyes
Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies. Therapeutic advances in hematology 14 (2023)
Jan Astermark, Jan Blatny, Christoph Königs, Cedric Hermans, Victor Jiménez-Yuste, Daniel P Hart
Considerations for shared decision management in previously untreated patients with hemophilia A or B. Therapeutic advances in hematology 14 (2023)
Hao Wang, Kristin N Berger, Elizabeth L Miller, Wei Fu, Larisa Broglie, Frederick D Goldman, Heiko Konig, Su Jin Lim, Arthur S Berg, Julie-An Talano, Melanie A Comito, Sherif S Farag, Jeffrey J Pu
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. Therapeutic advances in hematology 14 (2023)
Alexander Ngwube, Hemalatha G Rangarajan, Niketa Shah
Role of abatacept in the prevention of graft- versus -host disease: current perspectives. Therapeutic advances in hematology 14 (2023)
Jan Astermark, Jan Blatny, Christoph Königs, Cedric Hermans, Victor Jiménez-Yuste, Daniel P Hart
Considerations for shared decision management in previously untreated patients with hemophilia A or B. Therapeutic advances in hematology 14 (2023)
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Zdeněk Ráčil, Julio Dávila-Valls, Sonia Martín-Pérez, Jaap Van Doesum, Francesco Passamonti, Ghaith Abu-Zeinah, Francesca Farina, Alberto López-García, Giulia Dragonetti, Chiara Cattaneo, Maria Gomes Da Silva, Yavuz M Bilgin, Pavel Žák, Verena Petzer, Andreas Glenthøj, Ildefonso Espigado, Caterina Buquicchio, Valentina Bonuomo, Lucia Prezioso, Stef Meers, Rafael Duarte, Rui Bergantim, Ozren Jaksic, Natasha Čolović, Ola Blennow, Martin Cernan, Martin Schönlein, Michail Samarkos, Maria Enza Mitra, Gabriele Magliano, Johan Maertens, Marie-Pierre Ledoux, Moraima Jiménez, Fatih Demirkan, Graham P Collins, Alba Cabirta, Stefanie K Gräfe, Anna Nordlander, Dominik Wolf, Elena Arellano, Raul Cordoba, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Raquel Nunes Rodrigues, Giulia Limberti, Francesco Marchesi, Oliver A Cornely, Livio Pagano
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. Therapeutic advances in hematology 14 (2023)
Manfred Welslau, Boris Kubuschok, Julian Topaly, Burkhard Otremba, Thomas Wolff, Galyna Bryn
REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon ® ) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma. Therapeutic advances in hematology 14 (2023)
Lejun Huang, Jianxuan Xu, Huaying Zhang, Mengfan Wang, Yiyue Zhang, Qing Lin
Application and investigation of thrombopoiesis-stimulating agents in the treatment of thrombocytopenia. Therapeutic advances in hematology 14 (2023)
Lejun Huang, Jianxuan Xu, Huaying Zhang, Mengfan Wang, Yiyue Zhang, Qing Lin
Application and investigation of thrombopoiesis-stimulating agents in the treatment of thrombocytopenia. Therapeutic advances in hematology 14 (2023)
Xiaoying Zhang, Xingcheng Yang, Ling Ma, Yicheng Zhang, Jia Wei
Immune dysregulation and potential targeted therapy in myelodysplastic syndrome. Therapeutic advances in hematology 14 (2023)
Carmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, Ana R Cid, Kate Khair, Johannes Oldenburg, Claude Négrier, Jaco Botha, Aurelia Lelli, Jerzy Windyga
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study. Therapeutic advances in hematology 14 (2023)
Linchun Xu, Shaoze Lin, Xueyang Xing, Yongzhong Su
Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis. Therapeutic advances in hematology 14 (2023)
Fadi G Haddad, Jacki Sawyers, Nicholas James Short
Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Therapeutic advances in hematology 14 (2023)
Zhe Li, Wei Mu, Min Xiao
Genetic lesions and targeted therapy in Hodgkin lymphoma. Therapeutic advances in hematology 14 (2023)
Cedric Hermans, Yves Gruel, Laurent Frenzel, Evelien Krumb
How to translate and implement the current science of gene therapy into haemophilia care? Therapeutic advances in hematology 14 (2023)